nelfinavir has been researched along with m8-nelfinavir in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Hoon, J; Van Wijngaerden, E; Verbesselt, R | 1 |
| Bastiani, E; Donadel, E; Genco, F; Maserati, R; Meroni, V; Rinaldi, S; Uglietti, A | 1 |
| Auleley, S; Duval, X; Hirt, D; Mentré, F; Rey, E; Salmon, D; Tran, A; Tréluyer, JM | 1 |
| Chichino, G; Donadel, E; Genco, F; Ladisa, N; Malicarne, L; Martini, S; Masala, A; Maserati, R; Meroni, V; Narciso, P; Occhino, C; Perini, P; Ravasi, G; Testa, L; Uglietti, A | 1 |
| Biswas, P; Crownover, P; Damle, BD; Glue, P; Lin, C; Uderman, H | 1 |
| Akhtar, H; Boulassel, MR; Bourbeau, M; Burger, DM; Cameron, DW; Chauhan, BM; DelBalso, L; Foster, BC; Lalonde, RG; Seguin, I; Sheehan, NL; Singhal, N; van Heeswijk, RP | 1 |
| Best, BM; Capparelli, EV; Eke, AC; Kreitchmann, R; McCormack, SA; Mirochnick, M; Mofenson, LM; Shapiro, D; Smith, E; Stek, AM; Wang, J | 1 |
3 trial(s) available for nelfinavir and m8-nelfinavir
| Article | Year |
|---|---|
Influence of CYP2C19 polymorphism on the pharmacokinetics of nelfinavir and its active metabolite.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Cytochrome P-450 CYP2C19; Female; HIV Protease Inhibitors; Humans; Male; Metabolic Clearance Rate; Middle Aged; Nelfinavir; Polymorphism, Genetic; Young Adult | 2009 |
The effect of β-carotene supplementation on the pharmacokinetics of nelfinavir and its active metabolite M8 in HIV-1-infected patients.
Topics: Adult; Area Under Curve; beta Carotene; Dietary Supplements; Drug Stability; Female; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Male; Middle Aged; Nelfinavir; Viral Load | 2012 |
Pharmacokinetics of Increased Nelfinavir Plasma Concentrations in Women During Pregnancy and Postpartum.
Topics: Adult; Anti-HIV Agents; Female; HIV Protease Inhibitors; Humans; Nelfinavir; Postpartum Period; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies | 2019 |
4 other study(ies) available for nelfinavir and m8-nelfinavir
| Article | Year |
|---|---|
Simultaneous determination of 8 HIV protease inhibitors in human plasma by isocratic high-performance liquid chromatography with combined use of UV and fluorescence detection: amprenavir, indinavir, atazanavir, ritonavir, lopinavir, saquinavir, nelfinavir
Topics: Atazanavir Sulfate; Calibration; Carbamates; Chromatography, High Pressure Liquid; Drug Monitoring; Drug Stability; Fluorescence; Furans; HIV Protease Inhibitors; Humans; Indinavir; Lopinavir; Nelfinavir; Oligopeptides; Pyridines; Pyrimidinones; Reproducibility of Results; Ritonavir; Saquinavir; Sensitivity and Specificity; Sulfonamides; Ultraviolet Rays | 2007 |
Evaluation of Elisa test for therapeutic monitoring of Nelfinavir in HIV-positive patients.
Topics: Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Drug Monitoring; Enzyme-Linked Immunosorbent Assay; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Nelfinavir; Reagent Kits, Diagnostic; Sensitivity and Specificity | 2007 |
Effect of CYP2C19 polymorphism on nelfinavir to M8 biotransformation in HIV patients.
Topics: Adult; Aryl Hydrocarbon Hydroxylases; Biotransformation; Body Weight; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP3A; Dose-Response Relationship, Drug; Female; Genotype; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Mixed Function Oxygenases; Nelfinavir; Polymorphism, Genetic; Treatment Outcome; Viral Load | 2008 |
Nelfinavir+M8 plasma levels determined with an ELISA test in HIV infected patients with or without HCV and/or HBV coinfection: the VIRAKINETICS II study.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Enzyme-Linked Immunosorbent Assay; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; HIV Infections; Humans; Male; Middle Aged; Nelfinavir; Plasma | 2009 |